Back to Results
First PageMeta Content
Immunology / Glycoproteins / Antibodies / Immunoglobulin G / Immunoglobulin D / B cell / Immunoglobulin class switching / Monoclonal antibody therapy / Immunoglobulin E / Biology / Immune system / Anatomy


09_17_Mix_JON_S_5002[removed]
Add to Reading List

Document Date: 2013-01-01 12:44:16

Open Document

File Size: 323,76 KB

Share Result on Facebook

City

Rostock / Paris / Philadelphia / New York / Berlin / Cambridge / /

Company

TD Ag / Trip SA / tertiary Ab / Stimulatory Ab / Chambers SA / IgM / IgG / monoclonal Ab / Additional Ag / IgD / Cox / TI1 Ag / Igs / IgA / After Ag / Kao / IgE / /

/

Facility

U. K. Zettl University of Rostock Dept. / terminal Fc-fragment / /

/

IndustryTerm

cancer therapy / physical and chemical principles / inevitable tool / indispensable tools / chemical nature / treatment of autoimmune diseases / treatment of B cell leukemia / anti-idiotype network / /

MedicalCondition

insulin-dependent diabetes mellitus / Ab-dependent hypersensitivity / Multiple myeloma / IgE-mediated anaphylactic hypersensitivity / neurological disorders / rheumatoid arthritis / diphtheria / schistosomiasis / Immune complex-mediated hypersensitivity / BTK deficiency / inflammatory mediators / erythroblastosis fetalis / localized Arthus reaction / colon and breast cancer / multiple sclerosis / infectious agent / Grave’s disease / inflammatory diseases / asthma / leukemia / tumor / autoimmune disorders / Allergic diseases / cell leukemia / cancer / Rhesus disease / agammaglobulinemia / X-linked agammaglobulinemia / lymphomas / cytotoxic hypersensitivity / allergy / allergic reactions / non-Hodgkin lymphoma / AIDS / SLE / Colon cancer Colon cancer Leukemias / systemic lupus erythematosus / lymphoma / Hodgkin’s disease / allergic reactions underlying disease / Chronic lymphocytic leukemia / graft-versus-host disease / therapeutical trials Name Target Characteristics Indication Abciximab Alemtuzumab Basiliximab Bevacizumab Cetuximab Daclizumab Efalizumab Gemtuzumab GPIIb/IIIa CD52 CD25 VEGF EGFR CD25 CD11a CD33 Angina pectoris / rabies / solid tumors / chronic inflammatory demyelinating polyneuropathy / hyperthyroidism / colitis / ulcerosa Allergic rhinitis / Acute myeloid leukemia Lymphoma / J Allergy / hay fever / leukemias / hypersensitivity / chronic graft rejection / MS / Lupus / infections / patients’ cancer / myasthenia gravis / Dissociation / autoimmune diseases / SLE Breast cancer / cell lymphoma / hemolytic anemia / plasmocytoma / asthma B / Severe combined immunodeficiency / disease / macroglobulinemia / monoclonal gammopathy / myocardial infarction B / Crohn’s disease / rare IgE plasmocytoma / neurological disease / chronic lymphatic leukemia / infectious diseases / B cell leukemia / /

MedicalTreatment

cancer therapy / cell therapy / immunization / blood transfusion / passive immunization / AID / antibody therapy / /

MusicGroup

Yes / /

Organization

Combinatorial association / U. K. Zettl University of Rostock Dept. of Neurology Gehlsheimer Str. / /

Person

Niels Kay Jerne / Hans Bennich / Emil von Behring / Ann Immunol / Gerald M. Edelman / Karl Landsteiner / Robin R. A. Coombs / Shibasaburo Kitasato / Nils Kay Jerne / S. Gunnar O. Johansson / Oswald Avery / David W.Talmage / Jules Héricourt / Charles Robert Richet / Forrest Kendall / Abstract Immunoglobulins (Igs) / E. Mix / Paul Ehrlich / Rodney R. Porter / Walter de Gruyter / Michael Heidelberger / Macfarlane Burnet / /

/

Position

Porter / /

Product

CAMPATH / penicillin / /

ProgrammingLanguage

V / /

ProvinceOrState

Mississippi / /

Technology

genetic engineering / cell therapy / stem cells / apoptosis / treating cancer / recombination / cell receptors / antibodies / hybridization / ATM / Transplantation / /

SocialTag